Atoxigenic NF-κB suppressors may contribute to a reduced anti-apoptotic threshold of drug resistance, potentially enlarging the sensitivity of medications and thus the suppressive effects of medications on tumor cells may become more significant [34]. Here, NFKB1 is linked to neoplasm.